PTCH1 and medulloblastoma: In a mouse model of Ptch1+/- derived medulloblastoma, I-BET151 treatment dose-dependently reduces the viability of isolated cancer stem cells, significantly suppresses the growth of medulloblastoma in vivo, and lowers the expression level of the Hh target gene GLI1 (25).